Now I have all the information I need. Let me produce the final review.

## Summary

ProtEx is a retrieval-augmented approach for protein function prediction that retrieves positive and negative exemplar sequences for each candidate label (via BLAST or a similar similarity search) and conditions a Transformer model on concatenated query/exemplar inputs to make independent binary predictions. The method introduces a novel multi-sequence pretraining objective over unlabeled sequence pairs (predicting masked residues and a normalised Levenshtein similarity score), then fine-tunes on labeled data with careful exemplar sampling strategies. Experiments across Enzyme Commission (EC) numbers, Gene Ontology (GO) terms, and Pfam families show consistent improvements over both homology-based (BLAST) and deep learning baselines, with the largest gains on rare classes and low-similarity sequences.

## Strengths

- **State-of-the-art results across multiple protein function prediction tasks.** Tables 2–5 show ProtEx outperforming all prior methods on EC (random and clustered splits), GO, PDB EC, NEW-392, Price-149, and Pfam. For example, on the clustered EC split (Table 2) ProtEx achieves max F1 0.958 vs. BLAST's 0.950 and ProteinInfer's 0.930; on Pfam (Table 5) it achieves 92.6% family accuracy vs. the prior best (ProtTNN ensemble) at 89.7%.

- **Novel multi-sequence pretraining objective improves downstream performance.** Table 7 ablates pretraining on clustered EC: the proposed sequence-pair pretraining (with or without similarity score) yields F1 0.956–0.958, clearly above single-sequence pretraining (0.952) and no pretraining (0.912). This directly supports the claim that the pair-based objective is beneficial for the retrieval-augmented setting.

- **Disproportionate gains on rare classes and low-similarity sequences.** Figure 5 shows ProtEx maintains ~0.9 family accuracy across all training-set family sizes on Pfam, while ProtTNN and ProtENN drop to ~0.8 or below on the smallest bins. The stratified analysis (Section 4.4) confirms this extends to sequences with low sequence identity to the training set.

- **Ablation confirms the necessity of conditioning on exemplars.** Across all four task families (Tables 2–5), removing exemplars ("ProtEx no exemplars") causes substantial performance drops. For instance, on Pfam (Table 5) family accuracy falls from 92.6% to 76.3%. This evidences that the retrieval-augmented mechanism, not just the neural backbone, drives the gains.

- **Exemplar sampling strategy analysis is informative.** Figure 6 demonstrates that uniform sampling during training aligns the training similarity distribution with the evaluation distribution on Pfam, translating to higher development accuracy (91.85% vs. top-k's 89.39%). This provides practical guidance for handling distribution shift.

## Weaknesses

### Fatal
None.

### Major

1. **The Pfam retriever differs from BLAST, and the large improvement over BLAST is not fully isolated.** On the Pfam task (Section 4.4, Table 5), the authors replace BLAST with a custom retriever that randomly samples sequences per class and ranks them by a local alignment score. BLAST achieves only 64.1% family accuracy on this split — far below ProtEx's 92.6%. The paper acknowledges this substitution (line 353: "we use an alternative to BLAST") but does not report (a) a version of ProtEx using BLAST for Pfam retrieval, nor (b) the custom retriever's performance as a standalone baseline (e.g., majority-vote transfer from retrieved sequences). Since the Pfam result is the paper's largest absolute improvement, the source of the gain — improved retrieval or the neural model — is ambiguous. This is the paper's most significant evidential gap.

2. **Missing comparisons with directly related retrieval-augmented protein methods.** The Related Work (Section 2) mentions Hamamsy et al. (2023), Dickson & Mofrad (2023), and Zhang et al. (2024) as methods that combine retrieval and neural models for protein function. None of these are included as baselines. Given that the paper's contribution is a retrieval-augmented approach, the absence of these baselines makes it difficult to assess whether ProtEx's specific design choices (multi-sequence pretraining, independent binary predictions per candidate label, learned aggregation of exemplars) are advantageous over other retrieval-augmented designs.

### Minor

1. **"Unseen labels" terminology slightly overstates the experimental scope.** The abstract claims "generalization to unseen classes" and the introduction claims "generalization to labels not seen at training time." The experiment (Section 4.5) removes 10% of labels from fine-tuning but retains them in the retrieval database — so the model can retrieve positive exemplars for those labels at inference. This is a zero-shot / few-shot transfer scenario with access to labeled exemplars, not generalization to truly novel classes for which no annotations exist (the "dark matter" problem mentioned in the introduction). The experimental result is still interesting and well-executed, but the framing should be more precise.

2. **No sensitivity analysis of the number of positive/negative exemplars (k^p/k^n).** The paper uses 2/2 for EC/GO and 4/0 for Pfam but does not show how varying these affects performance. Given that the context window limits the number of exemplars and this is a central design parameter, readers cannot assess the robustness of these choices.

3. **No runtime or throughput comparison.** ProtEx requires up to |L̂_x| forward passes per query. The paper acknowledges computational cost as a limitation (Section 5) but does not report average candidate label counts or inference time relative to baselines, making it difficult to evaluate the accuracy-efficiency trade-off.

### Trivial
None.

## Nice-to-Haves
- The "Strengthening the Paper on Its Own Terms" section from the harsh critic suggests using BLAST for Pfam retrieval or providing a custom-retriever-only baseline, reframing the unseen-label experiment, and adding comparisons to Hamamsy/Dickson/Zhang. These suggestions are sensible directions for strengthening the paper.
- Including an analysis of the effect of varying k^p/k^n on accuracy.
- Reporting average candidate label counts and relative inference time.

## Removed Points

These points were flagged for removal from the main weaknesses — treat with caution:

- **"The 'unseen labels' experiment does not match the paper's framing of generalization to truly new classes"** — *Downgraded from the harsh critic's framing as a critical issue to Minor.* The paper's experiment is valid and clearly described; the issue is mainly about terminology precision. The paper states "generalization to labels not seen at training time" (line 78) which is accurate for what was done, and the abstract's "unseen classes" is common ML terminology for classes absent from the training set.
- **"Related Work description of ProtR is brief and dismissive"** — Removed. The paper clearly distinguishes ProtEx from ProtR and other methods in a few sentences; this is appropriate for a related work section that covers multiple methods.
- **"No analysis of negative sampling ratio during fine-tuning"** — Removed per the rule about missing appendix content. The paper explicitly states "See Appendix B.6 for details" (line 251), and the appendix was stripped by the parser.
- **Strength Finder's claim about "Strong generalization to unseen labels without retraining" was kept but reframed** — it is still a genuine experimental result, but the terminology should be more precise.

## Novel Insights

The reviews surface that the key tension in the paper is between the impressive breadth of empirical validation (EC, GO, Pfam across multiple splits, with careful ablations) and two specific design decisions that temper the strength of the claims: the Pfam retriever substitution and the omission of retrieval-augmented baselines. The harsh critic correctly identifies these as the issues most likely to affect the paper's impact, while the strength finder correctly identifies the consistent "no exemplars" ablation across all benchmarks as strong evidence that the retrieval mechanism matters. These two observations together suggest that the paper's core contribution — conditioning on retrieved exemplars via a learned, non-linear model — is well-supported on EC and GO, while the Pfam result needs tighter controls. An insightful observation not fully developed in either review is that the paper's multi-sequence pretraining objective (Table 7) provides a *principled* reason for why ProtEx might benefit from exemplars in ways that simpler aggregation methods (e.g., majority voting) would not: the model learns to compare sequences during pretraining, so fine-tuning extends this capability to class-specific distinctions.

## Suggestions

1. **Isolate the Pfam retriever contribution.** Run BLAST for ProtEx retrieval on Pfam (or at minimum, report the custom retriever's standalone accuracy via majority-vote label transfer from the top-K retrieved sequences). This would directly address the most significant evidential gap.

2. **Add at least one retrieval-augmented baseline.** Compare against ProtR (Zhang et al., 2024) or Dickson & Mofrad (2023) on at least one shared setting (e.g., the clustered EC split). This would position ProtEx within the emerging retrieval-augmented protein prediction landscape.

3. **Reframe the "unseen label" experiment as "generalization to labels not seen during fine-tuning"** (which the introduction already does) and explicitly clarify in the abstract and conclusion that this scenario still requires annotated exemplars in the retrieval database.

4. **Add a short section on exemplar count sensitivity** showing how performance varies with k^p and k^n on, e.g., the clustered EC development set. Even a small table would significantly strengthen the paper.

## Score and Decision

**Calibration anchors:**

| Paper | Avg Score | Round | Comparison |
|---|---|---|---|
| LLaPA (AK9uRqzLjt) | 4.75 | 1 | Weaker — less methodological novelty, narrower evaluation |
| ProtAC (R7l5kMJTut) | 5.20 | 1 | Weaker — different task, less clean contribution isolation |
| ProteinSSA (O0dW800ukz) | 5.67 | 1 | Weaker — unclear training, missing comparisons |
| ReNovo (uQnvYP7yX9) | 6.50 | 1 | Comparable — both retrieval-augmented SOTA, similar weakness severity |
| SaProt (6MRm3G4NiU) | 7.33 | 2 | Stronger — larger impact, cleaner evaluation, no equivalent of Pfam retriever concern |
| BioBridge (jJCeMiwHdH) | 7.00 | 2 | Stronger — cleaner framing, broader modality bridging |

My round-1 bracket was [5.5, 7.5]. Round 2 narrowed this by placing the paper above ProtAC/ProteinSSA (5.2–5.7) and comparable to ReNovo (6.5). The paper does not reach the level of SaProt (7.33) or BioBridge (7.0) due to the Pfam retriever ambiguity and missing retrieval-augmented baselines.

**Final score: 6.5**

This paper makes a genuine contribution — the multi-sequence pretraining, the exemplar-conditioned inference framework, and the comprehensive evaluation are all strengths. The weaknesses (Pfam retriever ambiguity, missing retrieval-augmented baselines) are fixable and do not invalidate the core contribution. The paper sits at the acceptance threshold: solid empirical work with clear value to the community, but with limitations that should be addressed in a revision.

MY FINAL SCORE: <score>6.5</score>
MY FINAL DECISION: <decision>Accept</decision>